SODIUM PHENYLACETATE AND SODIUM BENZOATE
Active substance: SODIUM PHENYLACETATE, SODIUM BENZOATE
INJECTION, SOLUTION, CONCENTRATE · SODIUM PHENYLACETATE 100 mg/mL, SODIUM BENZOATE 100 mg/mL
United StatesActive
Marketing holder: Zydus Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM PHENYLACETATE · 100 mg/mL
- SODIUM BENZOATE · 100 mg/mL
Registration
- Registration number
- 68382-396
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 68382-396 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68382-396 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68382-396 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 68382-396 · Verified 2026-10-09 · open in source